Free Trial
CVE:LBL

Lattice Biologics (LBL) Stock Price, News & Analysis

C$0.04
0.00 (0.00%)
(As of 06/3/2021)
Today's Range
C$0.04
C$0.04
50-Day Range
C$0.04
C$0.04
52-Week Range
C$0.03
C$0.13
Volume
114,000 shs
Average Volume
468,022 shs
Market Capitalization
C$5.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

LBL Stock Price History

LBL Stock News Headlines

See More Headlines
Receive LBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.56 million
Book Value
C$0.00 per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.13 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Guy S. Cook (Age 56)
    Chairman, Pres & CEO
    Comp: $360k
  • Ms. Donna Medina
    Interim Chief Financial Officer

LBL Stock Analysis - Frequently Asked Questions

How have LBL shares performed in 2024?

Lattice Biologics' stock was trading at C$0.04 at the beginning of 2024. Since then, LBL shares have increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Lattice Biologics own?
How do I buy shares of Lattice Biologics?

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:LBL) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners